nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA4—epilepsy syndrome	0.238	1	CbGaD
Dorzolamide—CA14—Lacosamide—epilepsy syndrome	0.0263	0.0486	CbGbCtD
Dorzolamide—CA6—Lacosamide—epilepsy syndrome	0.025	0.0461	CbGbCtD
Dorzolamide—CA5B—Lacosamide—epilepsy syndrome	0.0218	0.0402	CbGbCtD
Dorzolamide—CA9—Lacosamide—epilepsy syndrome	0.0187	0.0345	CbGbCtD
Dorzolamide—CA14—Acetazolamide—epilepsy syndrome	0.0181	0.0334	CbGbCtD
Dorzolamide—CA1—Lacosamide—epilepsy syndrome	0.0175	0.0323	CbGbCtD
Dorzolamide—CA5A—Acetazolamide—epilepsy syndrome	0.0172	0.0317	CbGbCtD
Dorzolamide—CA6—Acetazolamide—epilepsy syndrome	0.0172	0.0317	CbGbCtD
Dorzolamide—CA14—Zonisamide—epilepsy syndrome	0.0167	0.0309	CbGbCtD
Dorzolamide—CA4—Lacosamide—epilepsy syndrome	0.0164	0.0303	CbGbCtD
Dorzolamide—CA5A—Zonisamide—epilepsy syndrome	0.0159	0.0294	CbGbCtD
Dorzolamide—CA6—Zonisamide—epilepsy syndrome	0.0159	0.0294	CbGbCtD
Dorzolamide—CA2—Lacosamide—epilepsy syndrome	0.0151	0.0279	CbGbCtD
Dorzolamide—CA5B—Acetazolamide—epilepsy syndrome	0.015	0.0277	CbGbCtD
Dorzolamide—CA7—Acetazolamide—epilepsy syndrome	0.015	0.0277	CbGbCtD
Dorzolamide—CA7—Zonisamide—epilepsy syndrome	0.0139	0.0256	CbGbCtD
Dorzolamide—CA5B—Zonisamide—epilepsy syndrome	0.0139	0.0256	CbGbCtD
Dorzolamide—CA12—Acetazolamide—epilepsy syndrome	0.0129	0.0237	CbGbCtD
Dorzolamide—CA9—Acetazolamide—epilepsy syndrome	0.0129	0.0237	CbGbCtD
Dorzolamide—CA1—Acetazolamide—epilepsy syndrome	0.012	0.0222	CbGbCtD
Dorzolamide—CA12—Zonisamide—epilepsy syndrome	0.0119	0.022	CbGbCtD
Dorzolamide—CA9—Zonisamide—epilepsy syndrome	0.0119	0.022	CbGbCtD
Dorzolamide—CA6—Topiramate—epilepsy syndrome	0.0116	0.0214	CbGbCtD
Dorzolamide—CA5A—Topiramate—epilepsy syndrome	0.0116	0.0214	CbGbCtD
Dorzolamide—CA4—Acetazolamide—epilepsy syndrome	0.0113	0.0209	CbGbCtD
Dorzolamide—CA1—Zonisamide—epilepsy syndrome	0.0111	0.0206	CbGbCtD
Dorzolamide—CA4—Zonisamide—epilepsy syndrome	0.0105	0.0193	CbGbCtD
Dorzolamide—CA2—Acetazolamide—epilepsy syndrome	0.0104	0.0192	CbGbCtD
Dorzolamide—CA5B—Topiramate—epilepsy syndrome	0.0101	0.0187	CbGbCtD
Dorzolamide—CA7—Topiramate—epilepsy syndrome	0.0101	0.0187	CbGbCtD
Dorzolamide—CA2—Zonisamide—epilepsy syndrome	0.00961	0.0178	CbGbCtD
Dorzolamide—CA9—Topiramate—epilepsy syndrome	0.00867	0.016	CbGbCtD
Dorzolamide—CA12—Topiramate—epilepsy syndrome	0.00867	0.016	CbGbCtD
Dorzolamide—CA1—Topiramate—epilepsy syndrome	0.00811	0.015	CbGbCtD
Dorzolamide—CA4—Topiramate—epilepsy syndrome	0.00762	0.0141	CbGbCtD
Dorzolamide—CA2—Topiramate—epilepsy syndrome	0.00701	0.0129	CbGbCtD
Dorzolamide—CYP2C9—Trimethadione—epilepsy syndrome	0.0034	0.00628	CbGbCtD
Dorzolamide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0032	0.0059	CbGbCtD
Dorzolamide—CA6—ear—epilepsy syndrome	0.00316	0.156	CbGeAlD
Dorzolamide—CYP2C9—Carbamazepine—epilepsy syndrome	0.0023	0.00424	CbGbCtD
Dorzolamide—CYP2C9—Primidone—epilepsy syndrome	0.00214	0.00396	CbGbCtD
Dorzolamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00213	0.00393	CbGbCtD
Dorzolamide—Brinzolamide—CA4—epilepsy syndrome	0.00211	1	CrCbGaD
Dorzolamide—CYP2C9—Phenytoin—epilepsy syndrome	0.00206	0.0038	CbGbCtD
Dorzolamide—CYP3A4—Trimethadione—epilepsy syndrome	0.00198	0.00365	CbGbCtD
Dorzolamide—CYP3A4—Felbamate—epilepsy syndrome	0.00198	0.00365	CbGbCtD
Dorzolamide—CYP2C9—Propofol—epilepsy syndrome	0.00192	0.00355	CbGbCtD
Dorzolamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00186	0.00343	CbGbCtD
Dorzolamide—CYP2C9—Phenobarbital—epilepsy syndrome	0.00184	0.00339	CbGbCtD
Dorzolamide—CYP2C9—Diazepam—epilepsy syndrome	0.00174	0.00321	CbGbCtD
Dorzolamide—CYP3A4—Clonazepam—epilepsy syndrome	0.00168	0.0031	CbGbCtD
Dorzolamide—CYP3A4—Clobazam—epilepsy syndrome	0.00161	0.00298	CbGbCtD
Dorzolamide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00137	0.00253	CbGbCtD
Dorzolamide—CYP3A4—Rufinamide—epilepsy syndrome	0.00137	0.00253	CbGbCtD
Dorzolamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00133	0.00247	CbGbCtD
Dorzolamide—CYP3A4—Primidone—epilepsy syndrome	0.00125	0.0023	CbGbCtD
Dorzolamide—CYP3A4—Phenytoin—epilepsy syndrome	0.0012	0.00221	CbGbCtD
Dorzolamide—CYP3A4—Propofol—epilepsy syndrome	0.00112	0.00206	CbGbCtD
Dorzolamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00107	0.00197	CbGbCtD
Dorzolamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00107	0.00197	CbGbCtD
Dorzolamide—CYP3A4—Midazolam—epilepsy syndrome	0.00105	0.00194	CbGbCtD
Dorzolamide—CYP3A4—Diazepam—epilepsy syndrome	0.00101	0.00187	CbGbCtD
Dorzolamide—CYP3A4—Zonisamide—epilepsy syndrome	0.000987	0.00182	CbGbCtD
Dorzolamide—CA4—ganglion—epilepsy syndrome	0.000816	0.0404	CbGeAlD
Dorzolamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.000797	0.00147	CbGbCtD
Dorzolamide—CYP3A4—Topiramate—epilepsy syndrome	0.00072	0.00133	CbGbCtD
Dorzolamide—CA14—telencephalon—epilepsy syndrome	0.000652	0.0323	CbGeAlD
Dorzolamide—CA4—hindbrain—epilepsy syndrome	0.000619	0.0306	CbGeAlD
Dorzolamide—CA7—midbrain—epilepsy syndrome	0.000562	0.0278	CbGeAlD
Dorzolamide—CA12—forebrain—epilepsy syndrome	0.000553	0.0274	CbGeAlD
Dorzolamide—CA2—hindbrain—epilepsy syndrome	0.000513	0.0254	CbGeAlD
Dorzolamide—CA14—medulla oblongata—epilepsy syndrome	0.000512	0.0253	CbGeAlD
Dorzolamide—CA12—telencephalon—epilepsy syndrome	0.000508	0.0252	CbGeAlD
Dorzolamide—CA6—head—epilepsy syndrome	0.000472	0.0234	CbGeAlD
Dorzolamide—CA14—midbrain—epilepsy syndrome	0.000468	0.0232	CbGeAlD
Dorzolamide—CA14—spinal cord—epilepsy syndrome	0.000457	0.0226	CbGeAlD
Dorzolamide—CA1—forebrain—epilepsy syndrome	0.000438	0.0217	CbGeAlD
Dorzolamide—CA7—cerebellum—epilepsy syndrome	0.000435	0.0215	CbGeAlD
Dorzolamide—CA1—telencephalon—epilepsy syndrome	0.000403	0.0199	CbGeAlD
Dorzolamide—CA9—cerebellum—epilepsy syndrome	0.000382	0.0189	CbGeAlD
Dorzolamide—CA14—cerebellum—epilepsy syndrome	0.000362	0.0179	CbGeAlD
Dorzolamide—CA4—brainstem—epilepsy syndrome	0.000355	0.0175	CbGeAlD
Dorzolamide—CA7—brain—epilepsy syndrome	0.000353	0.0175	CbGeAlD
Dorzolamide—CA4—forebrain—epilepsy syndrome	0.000342	0.0169	CbGeAlD
Dorzolamide—CA12—head—epilepsy syndrome	0.000316	0.0157	CbGeAlD
Dorzolamide—CA4—telencephalon—epilepsy syndrome	0.000315	0.0156	CbGeAlD
Dorzolamide—CA12—nervous system—epilepsy syndrome	0.0003	0.0148	CbGeAlD
Dorzolamide—CA14—brain—epilepsy syndrome	0.000294	0.0146	CbGeAlD
Dorzolamide—CA2—brainstem—epilepsy syndrome	0.000294	0.0146	CbGeAlD
Dorzolamide—CA12—central nervous system—epilepsy syndrome	0.000289	0.0143	CbGeAlD
Dorzolamide—CA5B—head—epilepsy syndrome	0.000284	0.014	CbGeAlD
Dorzolamide—CA2—forebrain—epilepsy syndrome	0.000284	0.014	CbGeAlD
Dorzolamide—CA1—spinal cord—epilepsy syndrome	0.000282	0.014	CbGeAlD
Dorzolamide—CA5B—nervous system—epilepsy syndrome	0.000269	0.0133	CbGeAlD
Dorzolamide—CA2—telencephalon—epilepsy syndrome	0.000261	0.0129	CbGeAlD
Dorzolamide—CA5B—central nervous system—epilepsy syndrome	0.000259	0.0128	CbGeAlD
Dorzolamide—CA1—head—epilepsy syndrome	0.000251	0.0124	CbGeAlD
Dorzolamide—CA4—medulla oblongata—epilepsy syndrome	0.000247	0.0122	CbGeAlD
Dorzolamide—CA1—nervous system—epilepsy syndrome	0.000238	0.0118	CbGeAlD
Dorzolamide—CA12—brain—epilepsy syndrome	0.000229	0.0113	CbGeAlD
Dorzolamide—CA1—central nervous system—epilepsy syndrome	0.000229	0.0113	CbGeAlD
Dorzolamide—CA4—midbrain—epilepsy syndrome	0.000226	0.0112	CbGeAlD
Dorzolamide—CA4—spinal cord—epilepsy syndrome	0.00022	0.0109	CbGeAlD
Dorzolamide—CA5B—brain—epilepsy syndrome	0.000206	0.0102	CbGeAlD
Dorzolamide—CA2—medulla oblongata—epilepsy syndrome	0.000205	0.0101	CbGeAlD
Dorzolamide—CA4—head—epilepsy syndrome	0.000196	0.0097	CbGeAlD
Dorzolamide—CA2—midbrain—epilepsy syndrome	0.000187	0.00927	CbGeAlD
Dorzolamide—CA4—nervous system—epilepsy syndrome	0.000186	0.00919	CbGeAlD
Dorzolamide—CA2—spinal cord—epilepsy syndrome	0.000183	0.00905	CbGeAlD
Dorzolamide—CA1—brain—epilepsy syndrome	0.000182	0.00899	CbGeAlD
Dorzolamide—CA4—central nervous system—epilepsy syndrome	0.000179	0.00885	CbGeAlD
Dorzolamide—CA4—cerebellum—epilepsy syndrome	0.000175	0.00865	CbGeAlD
Dorzolamide—CA2—head—epilepsy syndrome	0.000162	0.00804	CbGeAlD
Dorzolamide—CA2—nervous system—epilepsy syndrome	0.000154	0.00762	CbGeAlD
Dorzolamide—CA2—central nervous system—epilepsy syndrome	0.000148	0.00734	CbGeAlD
Dorzolamide—CA2—cerebellum—epilepsy syndrome	0.000145	0.00717	CbGeAlD
Dorzolamide—CA4—brain—epilepsy syndrome	0.000142	0.00703	CbGeAlD
Dorzolamide—CA2—brain—epilepsy syndrome	0.000118	0.00583	CbGeAlD
Dorzolamide—CYP3A4—nervous system—epilepsy syndrome	9.94e-05	0.00492	CbGeAlD
Dorzolamide—CYP3A4—central nervous system—epilepsy syndrome	9.57e-05	0.00474	CbGeAlD
Dorzolamide—Tension—Gabapentin—epilepsy syndrome	3.74e-05	0.000292	CcSEcCtD
Dorzolamide—Vomiting—Fosphenytoin—epilepsy syndrome	3.74e-05	0.000292	CcSEcCtD
Dorzolamide—Diarrhoea—Felbamate—epilepsy syndrome	3.74e-05	0.000292	CcSEcCtD
Dorzolamide—Vertigo—Pregabalin—epilepsy syndrome	3.73e-05	0.000292	CcSEcCtD
Dorzolamide—Abdominal pain—Lamotrigine—epilepsy syndrome	3.73e-05	0.000292	CcSEcCtD
Dorzolamide—Body temperature increased—Lamotrigine—epilepsy syndrome	3.73e-05	0.000292	CcSEcCtD
Dorzolamide—Dysgeusia—Gabapentin—epilepsy syndrome	3.73e-05	0.000292	CcSEcCtD
Dorzolamide—Dizziness—Diazepam—epilepsy syndrome	3.73e-05	0.000292	CcSEcCtD
Dorzolamide—Syncope—Pregabalin—epilepsy syndrome	3.73e-05	0.000291	CcSEcCtD
Dorzolamide—Rash—Fosphenytoin—epilepsy syndrome	3.71e-05	0.00029	CcSEcCtD
Dorzolamide—Dermatitis—Fosphenytoin—epilepsy syndrome	3.7e-05	0.00029	CcSEcCtD
Dorzolamide—Nervousness—Gabapentin—epilepsy syndrome	3.7e-05	0.000289	CcSEcCtD
Dorzolamide—Asthenia—Clonazepam—epilepsy syndrome	3.7e-05	0.000289	CcSEcCtD
Dorzolamide—Back pain—Gabapentin—epilepsy syndrome	3.69e-05	0.000288	CcSEcCtD
Dorzolamide—Headache—Fosphenytoin—epilepsy syndrome	3.68e-05	0.000288	CcSEcCtD
Dorzolamide—Palpitations—Pregabalin—epilepsy syndrome	3.67e-05	0.000287	CcSEcCtD
Dorzolamide—Asthenia—Phenytoin—epilepsy syndrome	3.67e-05	0.000287	CcSEcCtD
Dorzolamide—Nausea—Midazolam—epilepsy syndrome	3.66e-05	0.000286	CcSEcCtD
Dorzolamide—Hallucination—Topiramate—epilepsy syndrome	3.66e-05	0.000286	CcSEcCtD
Dorzolamide—Diarrhoea—Zonisamide—epilepsy syndrome	3.66e-05	0.000286	CcSEcCtD
Dorzolamide—Pharyngitis—Topiramate—epilepsy syndrome	3.66e-05	0.000286	CcSEcCtD
Dorzolamide—Loss of consciousness—Pregabalin—epilepsy syndrome	3.65e-05	0.000285	CcSEcCtD
Dorzolamide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.65e-05	0.000285	CcSEcCtD
Dorzolamide—Pruritus—Clonazepam—epilepsy syndrome	3.65e-05	0.000285	CcSEcCtD
Dorzolamide—Vomiting—Vigabatrin—epilepsy syndrome	3.64e-05	0.000285	CcSEcCtD
Dorzolamide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.63e-05	0.000283	CcSEcCtD
Dorzolamide—Cough—Pregabalin—epilepsy syndrome	3.63e-05	0.000283	CcSEcCtD
Dorzolamide—Pruritus—Phenytoin—epilepsy syndrome	3.62e-05	0.000283	CcSEcCtD
Dorzolamide—Nausea—Levetiracetam—epilepsy syndrome	3.62e-05	0.000283	CcSEcCtD
Dorzolamide—Rash—Vigabatrin—epilepsy syndrome	3.61e-05	0.000282	CcSEcCtD
Dorzolamide—Dizziness—Felbamate—epilepsy syndrome	3.61e-05	0.000282	CcSEcCtD
Dorzolamide—Dermatitis—Vigabatrin—epilepsy syndrome	3.61e-05	0.000282	CcSEcCtD
Dorzolamide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.6e-05	0.000282	CcSEcCtD
Dorzolamide—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.6e-05	0.000281	CcSEcCtD
Dorzolamide—Vision blurred—Gabapentin—epilepsy syndrome	3.59e-05	0.000281	CcSEcCtD
Dorzolamide—Headache—Vigabatrin—epilepsy syndrome	3.59e-05	0.000281	CcSEcCtD
Dorzolamide—Hypertension—Pregabalin—epilepsy syndrome	3.59e-05	0.00028	CcSEcCtD
Dorzolamide—Vomiting—Diazepam—epilepsy syndrome	3.59e-05	0.00028	CcSEcCtD
Dorzolamide—Anorexia—Valproic Acid—epilepsy syndrome	3.58e-05	0.00028	CcSEcCtD
Dorzolamide—Rash—Diazepam—epilepsy syndrome	3.56e-05	0.000278	CcSEcCtD
Dorzolamide—Dermatitis—Diazepam—epilepsy syndrome	3.55e-05	0.000278	CcSEcCtD
Dorzolamide—Visual impairment—Topiramate—epilepsy syndrome	3.55e-05	0.000277	CcSEcCtD
Dorzolamide—Chest pain—Pregabalin—epilepsy syndrome	3.54e-05	0.000277	CcSEcCtD
Dorzolamide—Arthralgia—Pregabalin—epilepsy syndrome	3.54e-05	0.000277	CcSEcCtD
Dorzolamide—Dizziness—Zonisamide—epilepsy syndrome	3.54e-05	0.000276	CcSEcCtD
Dorzolamide—Headache—Diazepam—epilepsy syndrome	3.54e-05	0.000276	CcSEcCtD
Dorzolamide—Anxiety—Pregabalin—epilepsy syndrome	3.53e-05	0.000276	CcSEcCtD
Dorzolamide—Diarrhoea—Clonazepam—epilepsy syndrome	3.53e-05	0.000276	CcSEcCtD
Dorzolamide—Hypotension—Valproic Acid—epilepsy syndrome	3.51e-05	0.000274	CcSEcCtD
Dorzolamide—Asthenia—Carbamazepine—epilepsy syndrome	3.51e-05	0.000274	CcSEcCtD
Dorzolamide—Diarrhoea—Phenytoin—epilepsy syndrome	3.5e-05	0.000274	CcSEcCtD
Dorzolamide—Discomfort—Pregabalin—epilepsy syndrome	3.5e-05	0.000273	CcSEcCtD
Dorzolamide—Nausea—Fosphenytoin—epilepsy syndrome	3.49e-05	0.000273	CcSEcCtD
Dorzolamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.48e-05	0.000272	CcSEcCtD
Dorzolamide—Erythema multiforme—Topiramate—epilepsy syndrome	3.48e-05	0.000272	CcSEcCtD
Dorzolamide—Angioedema—Gabapentin—epilepsy syndrome	3.48e-05	0.000272	CcSEcCtD
Dorzolamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.48e-05	0.000272	CcSEcCtD
Dorzolamide—Vomiting—Felbamate—epilepsy syndrome	3.47e-05	0.000271	CcSEcCtD
Dorzolamide—Dry mouth—Pregabalin—epilepsy syndrome	3.46e-05	0.00027	CcSEcCtD
Dorzolamide—Pruritus—Carbamazepine—epilepsy syndrome	3.46e-05	0.00027	CcSEcCtD
Dorzolamide—Rash—Felbamate—epilepsy syndrome	3.44e-05	0.000269	CcSEcCtD
Dorzolamide—Dermatitis—Felbamate—epilepsy syndrome	3.44e-05	0.000269	CcSEcCtD
Dorzolamide—Tinnitus—Topiramate—epilepsy syndrome	3.43e-05	0.000268	CcSEcCtD
Dorzolamide—Vertigo—Gabapentin—epilepsy syndrome	3.42e-05	0.000268	CcSEcCtD
Dorzolamide—Headache—Felbamate—epilepsy syndrome	3.42e-05	0.000267	CcSEcCtD
Dorzolamide—Confusional state—Pregabalin—epilepsy syndrome	3.42e-05	0.000267	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.42e-05	0.000267	CcSEcCtD
Dorzolamide—Syncope—Gabapentin—epilepsy syndrome	3.42e-05	0.000267	CcSEcCtD
Dorzolamide—Dizziness—Clonazepam—epilepsy syndrome	3.41e-05	0.000266	CcSEcCtD
Dorzolamide—Nausea—Vigabatrin—epilepsy syndrome	3.4e-05	0.000266	CcSEcCtD
Dorzolamide—Vomiting—Zonisamide—epilepsy syndrome	3.4e-05	0.000266	CcSEcCtD
Dorzolamide—Insomnia—Valproic Acid—epilepsy syndrome	3.39e-05	0.000265	CcSEcCtD
Dorzolamide—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.39e-05	0.000265	CcSEcCtD
Dorzolamide—Oedema—Pregabalin—epilepsy syndrome	3.39e-05	0.000265	CcSEcCtD
Dorzolamide—Asthenia—Lamotrigine—epilepsy syndrome	3.39e-05	0.000265	CcSEcCtD
Dorzolamide—Dizziness—Phenytoin—epilepsy syndrome	3.38e-05	0.000265	CcSEcCtD
Dorzolamide—Rash—Zonisamide—epilepsy syndrome	3.37e-05	0.000263	CcSEcCtD
Dorzolamide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.37e-05	0.000263	CcSEcCtD
Dorzolamide—Palpitations—Gabapentin—epilepsy syndrome	3.37e-05	0.000263	CcSEcCtD
Dorzolamide—Dermatitis—Zonisamide—epilepsy syndrome	3.37e-05	0.000263	CcSEcCtD
Dorzolamide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.000263	CcSEcCtD
Dorzolamide—Nausea—Diazepam—epilepsy syndrome	3.35e-05	0.000262	CcSEcCtD
Dorzolamide—Loss of consciousness—Gabapentin—epilepsy syndrome	3.35e-05	0.000262	CcSEcCtD
Dorzolamide—Headache—Zonisamide—epilepsy syndrome	3.35e-05	0.000262	CcSEcCtD
Dorzolamide—Dyspnoea—Valproic Acid—epilepsy syndrome	3.34e-05	0.000261	CcSEcCtD
Dorzolamide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.34e-05	0.000261	CcSEcCtD
Dorzolamide—Pruritus—Lamotrigine—epilepsy syndrome	3.34e-05	0.000261	CcSEcCtD
Dorzolamide—Shock—Pregabalin—epilepsy syndrome	3.34e-05	0.000261	CcSEcCtD
Dorzolamide—Somnolence—Valproic Acid—epilepsy syndrome	3.34e-05	0.000261	CcSEcCtD
Dorzolamide—Cough—Gabapentin—epilepsy syndrome	3.33e-05	0.00026	CcSEcCtD
Dorzolamide—Dyspepsia—Valproic Acid—epilepsy syndrome	3.3e-05	0.000258	CcSEcCtD
Dorzolamide—Hypertension—Gabapentin—epilepsy syndrome	3.29e-05	0.000257	CcSEcCtD
Dorzolamide—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.28e-05	0.000256	CcSEcCtD
Dorzolamide—Vomiting—Clonazepam—epilepsy syndrome	3.28e-05	0.000256	CcSEcCtD
Dorzolamide—Decreased appetite—Valproic Acid—epilepsy syndrome	3.26e-05	0.000255	CcSEcCtD
Dorzolamide—Alopecia—Topiramate—epilepsy syndrome	3.25e-05	0.000254	CcSEcCtD
Dorzolamide—Vomiting—Phenytoin—epilepsy syndrome	3.25e-05	0.000254	CcSEcCtD
Dorzolamide—Rash—Clonazepam—epilepsy syndrome	3.25e-05	0.000254	CcSEcCtD
Dorzolamide—Dermatitis—Clonazepam—epilepsy syndrome	3.25e-05	0.000254	CcSEcCtD
Dorzolamide—Arthralgia—Gabapentin—epilepsy syndrome	3.24e-05	0.000254	CcSEcCtD
Dorzolamide—Chest pain—Gabapentin—epilepsy syndrome	3.24e-05	0.000254	CcSEcCtD
Dorzolamide—Nausea—Felbamate—epilepsy syndrome	3.24e-05	0.000254	CcSEcCtD
Dorzolamide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.000253	CcSEcCtD
Dorzolamide—Fatigue—Valproic Acid—epilepsy syndrome	3.23e-05	0.000253	CcSEcCtD
Dorzolamide—Anxiety—Gabapentin—epilepsy syndrome	3.23e-05	0.000253	CcSEcCtD
Dorzolamide—Anorexia—Pregabalin—epilepsy syndrome	3.23e-05	0.000253	CcSEcCtD
Dorzolamide—Dizziness—Carbamazepine—epilepsy syndrome	3.23e-05	0.000252	CcSEcCtD
Dorzolamide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.23e-05	0.000252	CcSEcCtD
Dorzolamide—Headache—Clonazepam—epilepsy syndrome	3.23e-05	0.000252	CcSEcCtD
Dorzolamide—Rash—Phenytoin—epilepsy syndrome	3.23e-05	0.000252	CcSEcCtD
Dorzolamide—Dermatitis—Phenytoin—epilepsy syndrome	3.22e-05	0.000252	CcSEcCtD
Dorzolamide—Rash—Oxcarbazepine—epilepsy syndrome	3.21e-05	0.000251	CcSEcCtD
Dorzolamide—Pain—Valproic Acid—epilepsy syndrome	3.21e-05	0.000251	CcSEcCtD
Dorzolamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.21e-05	0.000251	CcSEcCtD
Dorzolamide—Headache—Phenytoin—epilepsy syndrome	3.21e-05	0.000251	CcSEcCtD
Dorzolamide—Erythema—Topiramate—epilepsy syndrome	3.21e-05	0.000251	CcSEcCtD
Dorzolamide—Discomfort—Gabapentin—epilepsy syndrome	3.21e-05	0.000251	CcSEcCtD
Dorzolamide—Headache—Oxcarbazepine—epilepsy syndrome	3.19e-05	0.000249	CcSEcCtD
Dorzolamide—Nausea—Zonisamide—epilepsy syndrome	3.18e-05	0.000248	CcSEcCtD
Dorzolamide—Dry mouth—Gabapentin—epilepsy syndrome	3.17e-05	0.000248	CcSEcCtD
Dorzolamide—Hypotension—Pregabalin—epilepsy syndrome	3.17e-05	0.000248	CcSEcCtD
Dorzolamide—Tension—Topiramate—epilepsy syndrome	3.15e-05	0.000246	CcSEcCtD
Dorzolamide—Dysgeusia—Topiramate—epilepsy syndrome	3.14e-05	0.000245	CcSEcCtD
Dorzolamide—Confusional state—Gabapentin—epilepsy syndrome	3.14e-05	0.000245	CcSEcCtD
Dorzolamide—Dizziness—Lamotrigine—epilepsy syndrome	3.12e-05	0.000244	CcSEcCtD
Dorzolamide—Nervousness—Topiramate—epilepsy syndrome	3.11e-05	0.000243	CcSEcCtD
Dorzolamide—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.11e-05	0.000243	CcSEcCtD
Dorzolamide—Oedema—Gabapentin—epilepsy syndrome	3.11e-05	0.000243	CcSEcCtD
Dorzolamide—Vomiting—Carbamazepine—epilepsy syndrome	3.11e-05	0.000243	CcSEcCtD
Dorzolamide—Back pain—Topiramate—epilepsy syndrome	3.1e-05	0.000242	CcSEcCtD
Dorzolamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.09e-05	0.000242	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.09e-05	0.000242	CcSEcCtD
Dorzolamide—Rash—Carbamazepine—epilepsy syndrome	3.08e-05	0.000241	CcSEcCtD
Dorzolamide—Dermatitis—Carbamazepine—epilepsy syndrome	3.08e-05	0.000241	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.07e-05	0.00024	CcSEcCtD
Dorzolamide—Insomnia—Pregabalin—epilepsy syndrome	3.07e-05	0.00024	CcSEcCtD
Dorzolamide—Nausea—Clonazepam—epilepsy syndrome	3.06e-05	0.000239	CcSEcCtD
Dorzolamide—Headache—Carbamazepine—epilepsy syndrome	3.06e-05	0.000239	CcSEcCtD
Dorzolamide—Shock—Gabapentin—epilepsy syndrome	3.06e-05	0.000239	CcSEcCtD
Dorzolamide—Paraesthesia—Pregabalin—epilepsy syndrome	3.05e-05	0.000238	CcSEcCtD
Dorzolamide—Nausea—Phenytoin—epilepsy syndrome	3.04e-05	0.000238	CcSEcCtD
Dorzolamide—Dyspnoea—Pregabalin—epilepsy syndrome	3.02e-05	0.000236	CcSEcCtD
Dorzolamide—Nausea—Oxcarbazepine—epilepsy syndrome	3.02e-05	0.000236	CcSEcCtD
Dorzolamide—Vision blurred—Topiramate—epilepsy syndrome	3.02e-05	0.000236	CcSEcCtD
Dorzolamide—Somnolence—Pregabalin—epilepsy syndrome	3.02e-05	0.000236	CcSEcCtD
Dorzolamide—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.01e-05	0.000235	CcSEcCtD
Dorzolamide—Vomiting—Lamotrigine—epilepsy syndrome	3e-05	0.000235	CcSEcCtD
Dorzolamide—Urticaria—Valproic Acid—epilepsy syndrome	2.98e-05	0.000233	CcSEcCtD
Dorzolamide—Rash—Lamotrigine—epilepsy syndrome	2.98e-05	0.000233	CcSEcCtD
Dorzolamide—Dermatitis—Lamotrigine—epilepsy syndrome	2.97e-05	0.000232	CcSEcCtD
Dorzolamide—Abdominal pain—Valproic Acid—epilepsy syndrome	2.97e-05	0.000232	CcSEcCtD
Dorzolamide—Body temperature increased—Valproic Acid—epilepsy syndrome	2.97e-05	0.000232	CcSEcCtD
Dorzolamide—Anorexia—Gabapentin—epilepsy syndrome	2.96e-05	0.000232	CcSEcCtD
Dorzolamide—Headache—Lamotrigine—epilepsy syndrome	2.96e-05	0.000231	CcSEcCtD
Dorzolamide—Decreased appetite—Pregabalin—epilepsy syndrome	2.95e-05	0.00023	CcSEcCtD
Dorzolamide—Fatigue—Pregabalin—epilepsy syndrome	2.92e-05	0.000229	CcSEcCtD
Dorzolamide—Hypotension—Gabapentin—epilepsy syndrome	2.91e-05	0.000227	CcSEcCtD
Dorzolamide—Nausea—Carbamazepine—epilepsy syndrome	2.9e-05	0.000227	CcSEcCtD
Dorzolamide—Pain—Pregabalin—epilepsy syndrome	2.9e-05	0.000227	CcSEcCtD
Dorzolamide—Vertigo—Topiramate—epilepsy syndrome	2.88e-05	0.000225	CcSEcCtD
Dorzolamide—Syncope—Topiramate—epilepsy syndrome	2.88e-05	0.000225	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.83e-05	0.000221	CcSEcCtD
Dorzolamide—Palpitations—Topiramate—epilepsy syndrome	2.83e-05	0.000221	CcSEcCtD
Dorzolamide—Loss of consciousness—Topiramate—epilepsy syndrome	2.82e-05	0.00022	CcSEcCtD
Dorzolamide—Insomnia—Gabapentin—epilepsy syndrome	2.81e-05	0.00022	CcSEcCtD
Dorzolamide—Nausea—Lamotrigine—epilepsy syndrome	2.8e-05	0.000219	CcSEcCtD
Dorzolamide—Cough—Topiramate—epilepsy syndrome	2.8e-05	0.000219	CcSEcCtD
Dorzolamide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.8e-05	0.000218	CcSEcCtD
Dorzolamide—Paraesthesia—Gabapentin—epilepsy syndrome	2.79e-05	0.000218	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.77e-05	0.000217	CcSEcCtD
Dorzolamide—Dyspnoea—Gabapentin—epilepsy syndrome	2.77e-05	0.000217	CcSEcCtD
Dorzolamide—Hypertension—Topiramate—epilepsy syndrome	2.77e-05	0.000216	CcSEcCtD
Dorzolamide—Somnolence—Gabapentin—epilepsy syndrome	2.77e-05	0.000216	CcSEcCtD
Dorzolamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.76e-05	0.000216	CcSEcCtD
Dorzolamide—Dyspepsia—Gabapentin—epilepsy syndrome	2.74e-05	0.000214	CcSEcCtD
Dorzolamide—Arthralgia—Topiramate—epilepsy syndrome	2.73e-05	0.000213	CcSEcCtD
Dorzolamide—Chest pain—Topiramate—epilepsy syndrome	2.73e-05	0.000213	CcSEcCtD
Dorzolamide—Anxiety—Topiramate—epilepsy syndrome	2.72e-05	0.000213	CcSEcCtD
Dorzolamide—Decreased appetite—Gabapentin—epilepsy syndrome	2.7e-05	0.000211	CcSEcCtD
Dorzolamide—Discomfort—Topiramate—epilepsy syndrome	2.7e-05	0.000211	CcSEcCtD
Dorzolamide—Urticaria—Pregabalin—epilepsy syndrome	2.69e-05	0.000211	CcSEcCtD
Dorzolamide—Asthenia—Valproic Acid—epilepsy syndrome	2.69e-05	0.00021	CcSEcCtD
Dorzolamide—Fatigue—Gabapentin—epilepsy syndrome	2.68e-05	0.00021	CcSEcCtD
Dorzolamide—Abdominal pain—Pregabalin—epilepsy syndrome	2.68e-05	0.00021	CcSEcCtD
Dorzolamide—Body temperature increased—Pregabalin—epilepsy syndrome	2.68e-05	0.00021	CcSEcCtD
Dorzolamide—Dry mouth—Topiramate—epilepsy syndrome	2.67e-05	0.000209	CcSEcCtD
Dorzolamide—Pain—Gabapentin—epilepsy syndrome	2.66e-05	0.000208	CcSEcCtD
Dorzolamide—Pruritus—Valproic Acid—epilepsy syndrome	2.65e-05	0.000207	CcSEcCtD
Dorzolamide—Confusional state—Topiramate—epilepsy syndrome	2.64e-05	0.000206	CcSEcCtD
Dorzolamide—Oedema—Topiramate—epilepsy syndrome	2.62e-05	0.000205	CcSEcCtD
Dorzolamide—Shock—Topiramate—epilepsy syndrome	2.57e-05	0.000201	CcSEcCtD
Dorzolamide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.57e-05	0.000201	CcSEcCtD
Dorzolamide—Feeling abnormal—Gabapentin—epilepsy syndrome	2.56e-05	0.0002	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.54e-05	0.000199	CcSEcCtD
Dorzolamide—Hyperhidrosis—Topiramate—epilepsy syndrome	2.53e-05	0.000198	CcSEcCtD
Dorzolamide—Hypersensitivity—Pregabalin—epilepsy syndrome	2.5e-05	0.000195	CcSEcCtD
Dorzolamide—Anorexia—Topiramate—epilepsy syndrome	2.49e-05	0.000195	CcSEcCtD
Dorzolamide—Dizziness—Valproic Acid—epilepsy syndrome	2.48e-05	0.000194	CcSEcCtD
Dorzolamide—Urticaria—Gabapentin—epilepsy syndrome	2.47e-05	0.000193	CcSEcCtD
Dorzolamide—Body temperature increased—Gabapentin—epilepsy syndrome	2.46e-05	0.000192	CcSEcCtD
Dorzolamide—Abdominal pain—Gabapentin—epilepsy syndrome	2.46e-05	0.000192	CcSEcCtD
Dorzolamide—Hypotension—Topiramate—epilepsy syndrome	2.45e-05	0.000191	CcSEcCtD
Dorzolamide—Asthenia—Pregabalin—epilepsy syndrome	2.43e-05	0.00019	CcSEcCtD
Dorzolamide—Pruritus—Pregabalin—epilepsy syndrome	2.4e-05	0.000188	CcSEcCtD
Dorzolamide—Vomiting—Valproic Acid—epilepsy syndrome	2.39e-05	0.000186	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.38e-05	0.000186	CcSEcCtD
Dorzolamide—Insomnia—Topiramate—epilepsy syndrome	2.37e-05	0.000185	CcSEcCtD
Dorzolamide—Rash—Valproic Acid—epilepsy syndrome	2.37e-05	0.000185	CcSEcCtD
Dorzolamide—Dermatitis—Valproic Acid—epilepsy syndrome	2.36e-05	0.000185	CcSEcCtD
Dorzolamide—Headache—Valproic Acid—epilepsy syndrome	2.35e-05	0.000184	CcSEcCtD
Dorzolamide—Paraesthesia—Topiramate—epilepsy syndrome	2.35e-05	0.000184	CcSEcCtD
Dorzolamide—Dyspnoea—Topiramate—epilepsy syndrome	2.33e-05	0.000182	CcSEcCtD
Dorzolamide—Somnolence—Topiramate—epilepsy syndrome	2.33e-05	0.000182	CcSEcCtD
Dorzolamide—Diarrhoea—Pregabalin—epilepsy syndrome	2.32e-05	0.000181	CcSEcCtD
Dorzolamide—Dyspepsia—Topiramate—epilepsy syndrome	2.3e-05	0.00018	CcSEcCtD
Dorzolamide—Hypersensitivity—Gabapentin—epilepsy syndrome	2.29e-05	0.000179	CcSEcCtD
Dorzolamide—Decreased appetite—Topiramate—epilepsy syndrome	2.27e-05	0.000178	CcSEcCtD
Dorzolamide—Fatigue—Topiramate—epilepsy syndrome	2.26e-05	0.000176	CcSEcCtD
Dorzolamide—Dizziness—Pregabalin—epilepsy syndrome	2.24e-05	0.000175	CcSEcCtD
Dorzolamide—Pain—Topiramate—epilepsy syndrome	2.24e-05	0.000175	CcSEcCtD
Dorzolamide—Asthenia—Gabapentin—epilepsy syndrome	2.23e-05	0.000174	CcSEcCtD
Dorzolamide—Nausea—Valproic Acid—epilepsy syndrome	2.23e-05	0.000174	CcSEcCtD
Dorzolamide—Pruritus—Gabapentin—epilepsy syndrome	2.2e-05	0.000172	CcSEcCtD
Dorzolamide—Vomiting—Pregabalin—epilepsy syndrome	2.16e-05	0.000169	CcSEcCtD
Dorzolamide—Feeling abnormal—Topiramate—epilepsy syndrome	2.16e-05	0.000169	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.14e-05	0.000167	CcSEcCtD
Dorzolamide—Rash—Pregabalin—epilepsy syndrome	2.14e-05	0.000167	CcSEcCtD
Dorzolamide—Dermatitis—Pregabalin—epilepsy syndrome	2.14e-05	0.000167	CcSEcCtD
Dorzolamide—Diarrhoea—Gabapentin—epilepsy syndrome	2.13e-05	0.000166	CcSEcCtD
Dorzolamide—Headache—Pregabalin—epilepsy syndrome	2.12e-05	0.000166	CcSEcCtD
Dorzolamide—Urticaria—Topiramate—epilepsy syndrome	2.08e-05	0.000162	CcSEcCtD
Dorzolamide—Abdominal pain—Topiramate—epilepsy syndrome	2.07e-05	0.000162	CcSEcCtD
Dorzolamide—Body temperature increased—Topiramate—epilepsy syndrome	2.07e-05	0.000162	CcSEcCtD
Dorzolamide—Dizziness—Gabapentin—epilepsy syndrome	2.06e-05	0.000161	CcSEcCtD
Dorzolamide—Nausea—Pregabalin—epilepsy syndrome	2.01e-05	0.000157	CcSEcCtD
Dorzolamide—Vomiting—Gabapentin—epilepsy syndrome	1.98e-05	0.000155	CcSEcCtD
Dorzolamide—Rash—Gabapentin—epilepsy syndrome	1.96e-05	0.000153	CcSEcCtD
Dorzolamide—Dermatitis—Gabapentin—epilepsy syndrome	1.96e-05	0.000153	CcSEcCtD
Dorzolamide—Headache—Gabapentin—epilepsy syndrome	1.95e-05	0.000152	CcSEcCtD
Dorzolamide—Hypersensitivity—Topiramate—epilepsy syndrome	1.93e-05	0.000151	CcSEcCtD
Dorzolamide—Asthenia—Topiramate—epilepsy syndrome	1.88e-05	0.000147	CcSEcCtD
Dorzolamide—Pruritus—Topiramate—epilepsy syndrome	1.85e-05	0.000145	CcSEcCtD
Dorzolamide—Nausea—Gabapentin—epilepsy syndrome	1.85e-05	0.000144	CcSEcCtD
Dorzolamide—Diarrhoea—Topiramate—epilepsy syndrome	1.79e-05	0.00014	CcSEcCtD
Dorzolamide—Dizziness—Topiramate—epilepsy syndrome	1.73e-05	0.000135	CcSEcCtD
Dorzolamide—Vomiting—Topiramate—epilepsy syndrome	1.66e-05	0.00013	CcSEcCtD
Dorzolamide—Rash—Topiramate—epilepsy syndrome	1.65e-05	0.000129	CcSEcCtD
Dorzolamide—Dermatitis—Topiramate—epilepsy syndrome	1.65e-05	0.000129	CcSEcCtD
Dorzolamide—Headache—Topiramate—epilepsy syndrome	1.64e-05	0.000128	CcSEcCtD
Dorzolamide—Nausea—Topiramate—epilepsy syndrome	1.55e-05	0.000121	CcSEcCtD
Dorzolamide—CA14—Metabolism—GPX1—epilepsy syndrome	1.02e-05	0.000146	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ABCB1—epilepsy syndrome	1e-05	0.000143	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ABCB1—epilepsy syndrome	1e-05	0.000143	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GPX1—epilepsy syndrome	9.96e-06	0.000142	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GPX1—epilepsy syndrome	9.96e-06	0.000142	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP2D6—epilepsy syndrome	9.92e-06	0.000142	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ADRA2A—epilepsy syndrome	9.85e-06	0.000141	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	9.82e-06	0.00014	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—BCHE—epilepsy syndrome	9.81e-06	0.00014	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—HMOX1—epilepsy syndrome	9.66e-06	0.000138	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCG2—epilepsy syndrome	9.57e-06	0.000137	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CAT—epilepsy syndrome	9.53e-06	0.000136	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA13—epilepsy syndrome	9.52e-06	0.000136	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP2D6—epilepsy syndrome	9.51e-06	0.000136	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ADRA2A—epilepsy syndrome	9.45e-06	0.000135	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—BCHE—epilepsy syndrome	9.41e-06	0.000134	CbGpPWpGaD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	9.37e-06	0.000134	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—SLC2A1—epilepsy syndrome	9.36e-06	0.000134	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP2C19—epilepsy syndrome	9.33e-06	0.000133	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GPX1—epilepsy syndrome	9.3e-06	0.000133	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GPX1—epilepsy syndrome	9.3e-06	0.000133	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ABCB1—epilepsy syndrome	9.27e-06	0.000132	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP11A1—epilepsy syndrome	9.27e-06	0.000132	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PLCB1—epilepsy syndrome	9.26e-06	0.000132	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—TH—epilepsy syndrome	9.23e-06	0.000132	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	9.18e-06	0.000131	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	9.12e-06	0.00013	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ADRA2A—epilepsy syndrome	9.06e-06	0.000129	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	9.05e-06	0.000129	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—BCHE—epilepsy syndrome	9.02e-06	0.000129	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	9e-06	0.000128	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—SLC2A1—epilepsy syndrome	8.97e-06	0.000128	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AGT—epilepsy syndrome	8.96e-06	0.000128	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PLCB1—epilepsy syndrome	8.88e-06	0.000127	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—TH—epilepsy syndrome	8.84e-06	0.000126	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—APOE—epilepsy syndrome	8.78e-06	0.000125	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AGT—epilepsy syndrome	8.74e-06	0.000125	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AGT—epilepsy syndrome	8.74e-06	0.000125	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GPX1—epilepsy syndrome	8.62e-06	0.000123	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—SLC2A1—epilepsy syndrome	8.6e-06	0.000123	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—APOE—epilepsy syndrome	8.56e-06	0.000122	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—APOE—epilepsy syndrome	8.56e-06	0.000122	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PLCB1—epilepsy syndrome	8.51e-06	0.000122	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—TH—epilepsy syndrome	8.48e-06	0.000121	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP2D6—epilepsy syndrome	8.36e-06	0.000119	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	8.23e-06	0.000118	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AGT—epilepsy syndrome	8.15e-06	0.000116	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AGT—epilepsy syndrome	8.15e-06	0.000116	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	8.12e-06	0.000116	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—APOE—epilepsy syndrome	7.99e-06	0.000114	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—APOE—epilepsy syndrome	7.99e-06	0.000114	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ADRA2A—epilepsy syndrome	7.96e-06	0.000114	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—BCHE—epilepsy syndrome	7.93e-06	0.000113	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—HMOX1—epilepsy syndrome	7.7e-06	0.00011	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	7.66e-06	0.000109	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CAT—epilepsy syndrome	7.6e-06	0.000108	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	7.59e-06	0.000108	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—SLC2A1—epilepsy syndrome	7.56e-06	0.000108	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AGT—epilepsy syndrome	7.55e-06	0.000108	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—POMC—epilepsy syndrome	7.54e-06	0.000108	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PLCB1—epilepsy syndrome	7.48e-06	0.000107	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—TH—epilepsy syndrome	7.45e-06	0.000106	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—APOE—epilepsy syndrome	7.4e-06	0.000106	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ABCB1—epilepsy syndrome	7.39e-06	0.000106	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—HMOX1—epilepsy syndrome	7.38e-06	0.000105	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—POMC—epilepsy syndrome	7.35e-06	0.000105	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—POMC—epilepsy syndrome	7.35e-06	0.000105	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CAT—epilepsy syndrome	7.28e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CERS1—epilepsy syndrome	7.22e-06	0.000103	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	7.22e-06	0.000103	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	7.22e-06	0.000103	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—FAR1—epilepsy syndrome	7.22e-06	0.000103	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADK—epilepsy syndrome	7.22e-06	0.000103	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PDXK—epilepsy syndrome	7.22e-06	0.000103	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ABCB1—epilepsy syndrome	7.09e-06	0.000101	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—HMOX1—epilepsy syndrome	7.08e-06	0.000101	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CAT—epilepsy syndrome	6.98e-06	9.97e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ALB—epilepsy syndrome	6.88e-06	9.82e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GPX1—epilepsy syndrome	6.87e-06	9.81e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—POMC—epilepsy syndrome	6.86e-06	9.8e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—POMC—epilepsy syndrome	6.86e-06	9.8e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ABCB1—epilepsy syndrome	6.79e-06	9.7e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ALB—epilepsy syndrome	6.7e-06	9.57e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ALB—epilepsy syndrome	6.7e-06	9.57e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	6.6e-06	9.42e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	6.6e-06	9.42e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GAMT—epilepsy syndrome	6.6e-06	9.42e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PNPO—epilepsy syndrome	6.6e-06	9.42e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GPX1—epilepsy syndrome	6.59e-06	9.41e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—POMC—epilepsy syndrome	6.36e-06	9.08e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GPX1—epilepsy syndrome	6.32e-06	9.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA13—epilepsy syndrome	6.28e-06	8.97e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ALB—epilepsy syndrome	6.26e-06	8.94e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ALB—epilepsy syndrome	6.26e-06	8.94e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HMOX1—epilepsy syndrome	6.22e-06	8.88e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CAT—epilepsy syndrome	6.14e-06	8.77e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA4—epilepsy syndrome	6.14e-06	8.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—QDPR—epilepsy syndrome	6.14e-06	8.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	6.12e-06	8.73e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AGT—epilepsy syndrome	6.02e-06	8.6e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTGS2—epilepsy syndrome	6.02e-06	8.59e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCB1—epilepsy syndrome	5.97e-06	8.53e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—APOE—epilepsy syndrome	5.9e-06	8.43e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTGS2—epilepsy syndrome	5.86e-06	8.37e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTGS2—epilepsy syndrome	5.86e-06	8.37e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ALB—epilepsy syndrome	5.8e-06	8.28e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AGT—epilepsy syndrome	5.78e-06	8.25e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—COX3—epilepsy syndrome	5.77e-06	8.24e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APOE—epilepsy syndrome	5.66e-06	8.08e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GPX1—epilepsy syndrome	5.55e-06	7.93e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AGT—epilepsy syndrome	5.54e-06	7.91e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTGS2—epilepsy syndrome	5.47e-06	7.82e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTGS2—epilepsy syndrome	5.47e-06	7.82e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	5.47e-06	7.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	5.47e-06	7.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	5.47e-06	7.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	5.47e-06	7.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	5.47e-06	7.81e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—APOE—epilepsy syndrome	5.43e-06	7.75e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	5.34e-06	7.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	5.31e-06	7.59e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—epilepsy syndrome	5.07e-06	7.24e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—POMC—epilepsy syndrome	5.07e-06	7.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	5e-06	7.14e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	5e-06	7.14e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	5e-06	7.14e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AGT—epilepsy syndrome	4.87e-06	6.95e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—POMC—epilepsy syndrome	4.86e-06	6.94e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	4.81e-06	6.88e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOE—epilepsy syndrome	4.77e-06	6.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	4.76e-06	6.8e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	4.76e-06	6.8e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	4.76e-06	6.8e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	4.76e-06	6.8e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	4.76e-06	6.8e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	4.76e-06	6.8e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—POMC—epilepsy syndrome	4.66e-06	6.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	4.65e-06	6.64e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	4.65e-06	6.64e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—epilepsy syndrome	4.62e-06	6.6e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.54e-06	6.49e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—epilepsy syndrome	4.43e-06	6.33e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	4.37e-06	6.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.35e-06	6.22e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.35e-06	6.22e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.35e-06	6.22e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.35e-06	6.22e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	4.25e-06	6.07e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—epilepsy syndrome	4.25e-06	6.07e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	4.14e-06	5.92e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	4.14e-06	5.92e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—POMC—epilepsy syndrome	4.1e-06	5.85e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.05e-06	5.78e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.05e-06	5.78e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—epilepsy syndrome	4.04e-06	5.78e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.03e-06	5.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	3.95e-06	5.65e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	3.95e-06	5.65e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—epilepsy syndrome	3.88e-06	5.54e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	3.87e-06	5.53e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.8e-06	5.43e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	3.79e-06	5.41e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—epilepsy syndrome	3.74e-06	5.33e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—epilepsy syndrome	3.72e-06	5.31e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.72e-06	5.31e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.65e-06	5.21e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.61e-06	5.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.61e-06	5.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.61e-06	5.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.61e-06	5.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.61e-06	5.15e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.41e-06	4.87e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.31e-06	4.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.3e-06	4.71e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.3e-06	4.71e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.3e-06	4.71e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—epilepsy syndrome	3.27e-06	4.67e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.18e-06	4.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.18e-06	4.53e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.07e-06	4.38e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.07e-06	4.38e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—epilepsy syndrome	3.02e-06	4.32e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3e-06	4.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3e-06	4.28e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—epilepsy syndrome	2.95e-06	4.21e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—epilepsy syndrome	2.95e-06	4.21e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.88e-06	4.12e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.8e-06	4.01e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.79e-06	3.98e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—epilepsy syndrome	2.75e-06	3.93e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—epilepsy syndrome	2.75e-06	3.93e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.73e-06	3.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.73e-06	3.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.73e-06	3.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.61e-06	3.72e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.61e-06	3.72e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.55e-06	3.64e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—epilepsy syndrome	2.55e-06	3.64e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.5e-06	3.57e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.45e-06	3.5e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.44e-06	3.49e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.41e-06	3.44e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.38e-06	3.4e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.37e-06	3.38e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.35e-06	3.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.25e-06	3.21e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.19e-06	3.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.14e-06	3.06e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.14e-06	3.05e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—epilepsy syndrome	2.03e-06	2.9e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.03e-06	2.9e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.02e-06	2.89e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.98e-06	2.82e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.98e-06	2.82e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—epilepsy syndrome	1.95e-06	2.78e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.93e-06	2.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.91e-06	2.73e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TH—epilepsy syndrome	1.9e-06	2.72e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.87e-06	2.68e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—epilepsy syndrome	1.87e-06	2.67e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—epilepsy syndrome	1.64e-06	2.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.61e-06	2.3e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.59e-06	2.27e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.57e-06	2.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.57e-06	2.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.56e-06	2.23e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.52e-06	2.18e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.42e-06	2.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.41e-06	2.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.34e-06	1.91e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.33e-06	1.91e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.27e-06	1.82e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.26e-06	1.8e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TH—epilepsy syndrome	1.25e-06	1.79e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.24e-06	1.77e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.22e-06	1.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.05e-06	1.5e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.05e-06	1.49e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.03e-06	1.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.01e-06	1.44e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—epilepsy syndrome	9.54e-07	1.36e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.35e-07	1.33e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	8.34e-07	1.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.2e-07	1.17e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.03e-07	1.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.9e-07	9.85e-06	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.29e-07	8.98e-06	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.5e-07	7.86e-06	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.19e-07	5.99e-06	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.77e-07	3.95e-06	CbGpPWpGaD
